Investigational New Drug Application (IND) Forms: Updates and Best Practices

  Рет қаралды 7,926

Duke University School of Medicine

Duke University School of Medicine

Күн бұрын

Presented at Duke University School of Medicine on April 15, 2019 by Daniel Tonkin, PhD, RAC

Пікірлер
Introduction to Investigational New Drug (IND) Applications (3/14) REdI 2017
46:00
U.S. Food and Drug Administration
Рет қаралды 18 М.
Success Factors in Your IND Filing
1:01:39
Regis Technologies, Inc.
Рет қаралды 9 М.
100❤️
00:19
MY💝No War🤝
Рет қаралды 14 МЛН
Looks realistic #tiktok
00:22
Анастасия Тарасова
Рет қаралды 96 МЛН
A Conversation with Dr. Anthony Fauci: A Storied Career in Public Health
6:44
Duke University School of Medicine
Рет қаралды 411
Developing Monitoring Plans for Investigator-Initiated Clinical Trials - November 14, 2017
58:13
Duke University School of Medicine
Рет қаралды 2,1 М.
"Basic Overview of Preclinical Toxicology - Animal Models"
1:00:52
The Neuroscience Behind the Placebo Effect
4:36
BrainFacts.org
Рет қаралды 63 М.
The Science and Practice of Low-Carb Diets {Duke University Office Hours}
42:42
U.S. FDA eCTD Requirements for Drug Master Files (DMFs)
57:40
Registrar Corp
Рет қаралды 16 М.
Chemistry, Manufacturing, and Controls (CMC) for an IND (7of14) REdI 2018
1:19:35
U.S. Food and Drug Administration
Рет қаралды 27 М.
2024 Duke School of Medicine State of the School Address
37:39
Duke University School of Medicine
Рет қаралды 564
How Does the FDA Approve a Drug?
7:38
Healthcare Triage
Рет қаралды 178 М.
100❤️
00:19
MY💝No War🤝
Рет қаралды 14 МЛН